Safety and Activity of the Chemotherapy-free Triplet of Ublituximab, TGR-1202 and ibrutinib in Relapsed B-cell Malignancies.

Drug Category: Array
Conference Category: Array
Lead Author: Fowler N, O'Brien S, et al.
Published Date: 02/06/2015
Download Link: /wp-content/uploads/2019/03/ASCO%20Triplet%20Fowler%20Final%20Presentation.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top